BridgeMD
New treatment option for Sudden Hearing Loss
Official title Yiyuancong for the Treatment of Sudden Sensorineural Hearing Loss
ClinicalTrials.gov ID: NCT07505667
What this study is testing
What is Standard treatment combined with Yiyuancong?
Standard treatment combined with Yiyuancong is an investigational medicine, given as an once-daily, being studied as a potential treatment for sudden hearing loss.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This project aims to evaluate the clinical efficacy of Yiyuancong, an independently developed traditional Chinese medicine (TCM) formula based on the homology of medicine and food, in participants with sudden sensorineural hearing loss (SSNHL) and to elucidate its potential underlying mechanisms. This study is designed as a multicenter, randomized controlled trial (RCT), utilizing dynamic randomization for participant allocation.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Unilateral sudden sensorineural hearing loss (SSNHL) occurring within 72 hours, with a hearing threshold decrease of 20 dB at at least two...
- Enrollment must be completed within 14 days of the onset of SSNHL.
- Males or females aged 18 to 60 years.
- Ability to understand the study protocol and comply with regular follow-up visits.
You likely can't join if
- Pregnancy or lactation (breastfeeding).
- History of chronic ear disease, prior ear surgery, autoimmune hearing loss, or a confirmed diagnosis of Meniere's disease.
- Receipt of corticosteroid therapy for any reason within the previous 30 days.
- Presence of autoimmune diseases or chronic inflammatory diseases.
- Severe hepatic or renal impairment.
- Any other condition that, in the opinion of the investigator, renders the participant unsuitable for inclusion.
The study team makes the final eligibility decision.
Where it's taking place
- Guangzhou, Guangdong, China
- Shenzhen, Guangdong, China
- Zhongshan, Guangdong, China
- Liuzhou, Guangxi, China
- Ganzhou, Jiangxi, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guangzhou, Guangdong, China; Shenzhen, Guangdong, China; Zhongshan, Guangdong, China; Liuzhou, Guangxi, China; Ganzhou, Jiangxi, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.